BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Youssef M, H Hussein M, Attia AS, M Elshazli R, Omar M, Zora G, S Farhoud A, Elnahla A, Shihabi A, Toraih EA, S Fawzy M, Kandil E. COVID-19 and liver dysfunction: A systematic review and meta-analysis of retrospective studies. J Med Virol. 2020;92:1825-1833. [PMID: 32445489 DOI: 10.1002/jmv.26055] [Cited by in Crossref: 38] [Cited by in F6Publishing: 49] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Farias JP, Codes L, Vinhaes D, Amorim AP, D'Oliveira RC, Farias AQ, Bittencourt PL. Impact of baseline abnormal liver enzymes in the outcome of COVID-19 infection. Transl Gastroenterol Hepatol 2023;8:5. [PMID: 36704646 DOI: 10.21037/tgh-22-41] [Reference Citation Analysis]
2 Domovitz T, Ayoub S, Werbner M, Alter J, Izhaki Tavor L, Yahalom-Ronen Y, Tikhonov E, Meirson T, Maman Y, Paran N, Israely T, Dessau M, Gal-Tanamy M. HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State. Microbiol Spectr 2022;10:e0115022. [PMID: 36314945 DOI: 10.1128/spectrum.01150-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chen H, Chen Q. COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD. Int J Biol Sci 2022;18:4756-67. [PMID: 35874945 DOI: 10.7150/ijbs.72461] [Reference Citation Analysis]
4 Rasyid Ridho M, Sukmagautama C, Dyanneza F. Profil Klinis dan Epidemiologi Pasien Covid-19 di Sukoharjo. Plexus Med J 2022;1:81-92. [DOI: 10.20961/plexus.v1i3.44] [Reference Citation Analysis]
5 Săbiescu DM, Kamal AM, Kamal CK, Alexandru DO, Mitruț P. Liver damage in the context of SARS-CoV-2. Covid-19 treatment and its effects on the liver. J Med Life 2022;15:727-34. [PMID: 35928369 DOI: 10.25122/jml-2022-0177] [Reference Citation Analysis]
6 Antala S, Diamond T, Kociolek LK, Shah AA, Chapin CA. Severe Hepatitis in Pediatric Coronavirus Disease 2019. J Pediatr Gastroenterol Nutr 2022;74:631-5. [PMID: 35149651 DOI: 10.1097/MPG.0000000000003404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
7 Barajas-martínez A, Mehta R, Ibarra-coronado E, Fossion R, Martínez Garcés VJ, Arellano MR, González Alvarez IA, Bautista YVM, Bello-chavolla OY, Pedraza NR, Encinas BR, Carrión CIP, Ávila MIJ, Valladares-garcía JC, Vanegas-cedillo PE, Juárez DH, Vargas-vázquez A, Antonio-villa NE, Almeda-valdes P, Resendis-antonio O, Hiriart M, Frank A, Aguilar-salinas CA, Rivera AL. Physiological Network Is Disrupted in Severe COVID-19. Front Physiol 2022;13:848172. [DOI: 10.3389/fphys.2022.848172] [Reference Citation Analysis]
8 Shousha HI, Ramadan A, Lithy R, El-Kassas M. Patterns of liver profile disturbance in patients with COVID-19 . World J Clin Cases 2022; 10(7): 2063-2071 [DOI: 10.12998/wjcc.v10.i7.2063] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Vasquez-Elera LE, Failoc-Rojas VE, Martinez-Rivera RN, Morocho-Alburqueque N, Temoche-Rivas MS, Valladares-Garrido MJ. Self-medication in hospitalized patients with COVID-19: A cross-sectional study in northern Peru. Germs 2022;12:46-53. [PMID: 35601942 DOI: 10.18683/germs.2022.1305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 de Jesus RP, de Carvalho JF, de Oliveira LPM, Cunha CM, Alves TCHS, Vieira STB, Figueiredo VM, Bueno AA. Metabolic and nutritional triggers associated with increased risk of liver complications in SARS-CoV-2. World J Hepatol 2022; 14(1): 80-97 [DOI: 10.4254/wjh.v14.i1.80] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kodavoor Vadiraj P, Thareja S, Raman N, Karantha SC, Jayaraman M, Vardhan V. Does Raised Transaminases Predict Severity and Mortality in Patients with COVID 19? J Clin Exp Hepatol 2022;12:1114-23. [PMID: 35125781 DOI: 10.1016/j.jceh.2022.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kayaaslan B, Guner R. COVID-19 and the liver: A brief and core review. World J Hepatol 2021; 13(12): 2013-2023 [DOI: 10.4254/wjh.v13.i12.2013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Shousha HI, Afify S, Maher R, Asem N, Fouad E, Mostafa EF, Medhat MA, Abdalazeem A, Elmorsy H, Aziz MM, Mohammed RS, Ibrahem M, Elgarem H, Omran D, Hassany M, Elsayed B, Abdelaziz AY, El Kassas M. Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study. World J Gastroenterol 2021; 27(40): 6951-6966 [PMID: 34790017 DOI: 10.3748/wjg.v27.i40.6951] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Omar AS, Kaddoura R, Orabi B, Hanoura S. Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units. World J Hepatol 2021; 13(10): 1215-1233 [PMID: 34786163 DOI: 10.4254/wjh.v13.i10.1215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sodeifian F, Seyedalhosseini ZS, Kian N, Eftekhari M, Najari S, Mirsaeidi M, Farsi Y, Nasiri MJ. Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review. Front Med (Lausanne) 2021;8:731436. [PMID: 34616757 DOI: 10.3389/fmed.2021.731436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
16 Attia AS, Hussein M, Aboueisha MA, Omar M, Youssef MR, Mankowski N, Miller M, Munshi R, Swinford A, Kline A, Nguyen T, Toraih E, Duchesne J, Kandil E. Altered mental status is a predictor of poor outcomes in COVID-19 patients: A cohort study. PLoS One 2021;16:e0258095. [PMID: 34610034 DOI: 10.1371/journal.pone.0258095] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Nekaeva ES, Bolshakova AE, Malysheva ES, Galova EA, Makarova EV, Nekrasova TA, Polyakova IV, Bedretdinova ZS, Belikina DV, Lavrenyuk AA, Fomin IV. Gender Characteristics of the Novel Coronavirus Infection (COVID-19) in Middle-Aged Adults. Sovrem Tekhnologii Med 2021;13:16-24. [PMID: 34603760 DOI: 10.17691/stm2021.13.4.02] [Reference Citation Analysis]
18 Treskova-Schwarzbach M, Haas L, Reda S, Pilic A, Borodova A, Karimi K, Koch J, Nygren T, Scholz S, Schönfeld V, Vygen-Bonnet S, Wichmann O, Harder T. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med 2021;19:212. [PMID: 34446016 DOI: 10.1186/s12916-021-02058-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 15.5] [Reference Citation Analysis]
19 Du M, Yang DS, Liu M, Liu J. COVID-19 and Liver dysfunction: Epidemiology, Association and Potential Mechanisms. Clin Res Hepatol Gastroenterol 2021;:101793. [PMID: 34428501 DOI: 10.1016/j.clinre.2021.101793] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
20 Aloisio E, Colombo G, Arrigo C, Dolci A, Panteghini M. Sources and clinical significance of aspartate aminotransferase increases in COVID-19. Clin Chim Acta 2021;522:88-95. [PMID: 34411557 DOI: 10.1016/j.cca.2021.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Harrison SL, Buckley BJR, Rivera-Caravaca JM, Zhang J, Lip GYH. Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. Eur Heart J Qual Care Clin Outcomes 2021;7:330-9. [PMID: 34107535 DOI: 10.1093/ehjqcco/qcab029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
22 Samidoust P, Nikoupour H, Hemmati H, Samidoust A. Clinical Manifestations and Characterization of COVID-19 in Liver Transplant Recipients: A Systematic Review of Case Reports and Case Series. Ethiop J Health Sci 2021;31:429-38. [PMID: 34158795 DOI: 10.4314/ejhs.v31i2.26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Srivastava S, Garg I. Post COVID-19 infection: Long-term effects on liver and kidneys. World J Meta-Anal 2021; 9(3): 220-233 [DOI: 10.13105/wjma.v9.i3.220] [Reference Citation Analysis]
24 Hage R, Steinack C, Gautschi F, Pfister S, Inci I, Schuurmans MM. Clinical Characteristics, Treatments and Outcomes of 18 Lung Transplant Recipients with COVID-19. Transplantology 2021;2:229-45. [DOI: 10.3390/transplantology2020022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Leowattana W. Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients. World J Virol 2021; 10(3): 86-96 [PMID: 34079691 DOI: 10.5501/wjv.v10.i3.86] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kovalic AJ, Huang G, Thuluvath PJ, Satapathy SK. REPLY. Hepatology 2021;73:2080-1. [PMID: 32895966 DOI: 10.1002/hep.31542] [Reference Citation Analysis]
27 Wang T, Smith DA, Campbell C, Harris S, Salih H, Várnai KA, Woods K, Noble T, Freeman O, Moysova Z, Marjot T, Webb GJ, Davies J, Barnes E, Matthews PC. Longitudinal analysis of the utility of liver biochemistry in hospitalised COVID-19 patients as prognostic markers. Hepatol Commun 2021. [PMID: 34222741 DOI: 10.1002/hep4.1739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
28 Al-Nimer MS. Is COVID-19-induced liver injury different from other RNA viruses?‎ World J Meta-Anal 2021; 9(2): 108-127 [DOI: 10.13105/wjma.v9.i2.108] [Reference Citation Analysis]
29 Hwaiz R, Merza M, Hamad B, HamaSalih S, Mohammed M, Hama H. Evaluation of hepatic enzymes activities in COVID-19 patients. Int Immunopharmacol 2021;97:107701. [PMID: 33930704 DOI: 10.1016/j.intimp.2021.107701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
30 Fadl N, Ali E, Salem TZ. COVID-19: Risk Factors Associated with Infectivity and Severity. Scand J Immunol 2021;93:e13039. [PMID: 33710663 DOI: 10.1111/sji.13039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
31 Chang R, Elhusseiny KM, Yeh YC, Sun WZ. COVID-19 ICU and mechanical ventilation patient characteristics and outcomes-A systematic review and meta-analysis.PLoS One. 2021;16:e0246318. [PMID: 33571301 DOI: 10.1371/journal.pone.0246318] [Cited by in Crossref: 54] [Cited by in F6Publishing: 71] [Article Influence: 27.0] [Reference Citation Analysis]
32 Ugolotti MC, Pedrazzini M, Silini EM, Missale G, Silva M, Franzini C, Palmieri G, Costi R, Montali F, Gnappi E, Terroni L, Colizzi E, Meschi M, Facchinetti F. Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient. J Med Virol 2021;93:1940-2. [PMID: 33458846 DOI: 10.1002/jmv.26803] [Reference Citation Analysis]
33 Li G, Yang Y, Gao D, Xu Y, Gu J, Liu P. Is liver involvement overestimated in COVID-19 patients? Int J Med Sci. 2021;18:1285-1296. [PMID: 33526990 DOI: 10.7150/ijms.51174] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
34 Garrido M, Pereira Guedes T, Alves Silva J, Falcão D, Novo I, Archer S, Rocha M, Maia L, Sarmento-Castro R, Pedroto I. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19. GE Port J Gastroenterol 2021;158:1-12. [PMID: 34192127 DOI: 10.1159/000513593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Loo J, Spittle DA, Newnham M. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax 2021;76:412-20. [PMID: 33408195 DOI: 10.1136/thoraxjnl-2020-216243] [Cited by in Crossref: 122] [Cited by in F6Publishing: 132] [Article Influence: 61.0] [Reference Citation Analysis]
36 Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021;18:348-64. [PMID: 33692570 DOI: 10.1038/s41575-021-00426-4] [Cited by in Crossref: 172] [Cited by in F6Publishing: 173] [Article Influence: 86.0] [Reference Citation Analysis]
37 Barek MA, Aziz MA, Islam MS. Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases. Heliyon 2020;6:e05684. [PMID: 33344791 DOI: 10.1016/j.heliyon.2020.e05684] [Cited by in Crossref: 71] [Cited by in F6Publishing: 78] [Article Influence: 23.7] [Reference Citation Analysis]
38 Zhang S, Liu L, Yang B, Li R, Luo J, Huang J, Long Y, Huang Y, Zhou J, Zha Y, Zhang X. Clinical characteristics of 134 convalescent patients with COVID-19 in Guizhou, China. Respir Res 2020;21:314. [PMID: 33243228 DOI: 10.1186/s12931-020-01580-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
39 Bi J, Ma H, Zhang D, Huang J, Yang D, Wang Y, Verma V, Zhang T, Hu D, Mei Q, Han G, Li J. Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection? Eur Respir J 2020;56:2002672. [PMID: 32883679 DOI: 10.1183/13993003.02672-2020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
40 Abe K, Yamamoto T, Matsumoto K, Kikuchi K, Miura R, Tachizawa N, Asaoka Y, Takezawa T, Matsunaga N, Obi S, Tanaka A. Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population. Intern Med. 2020;59:2353-2358. [PMID: 32999264 DOI: 10.2169/internalmedicine.5777-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
41 Suresh Kumar VC, Harne PS, Mukherjee S, Gupta K, Masood U, Sharma AV, Lamichhane J, Dhamoon AS, Sapkota B. Transaminitis is an indicator of mortality in patients with COVID-19: A retrospective cohort study. World J Hepatol 2020; 12(9): 619-627 [PMID: 33033568 DOI: 10.4254/wjh.v12.i9.619] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
42 Chen LZ, Lin ZH, Chen J, Liu SS, Shi T, Xin YN. Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19? Epidemiol Infect. 2020;148:e218. [PMID: 32951624 DOI: 10.1017/s0950268820002186] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
43 Wang T, Smith DA, Campbell C, Harris S, Salih H, Várnai KA, Woods K, Noble T, Freeman O, Moysova Z, Marjot T, Webb GJ, Davies J, Barnes E, Matthews PC. Longitudinal analysis of the utility of liver biochemistry in hospitalised COVID-19 patients as prognostic markers.. [DOI: 10.1101/2020.09.15.20194985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Li C, Chen Q, Wang J, Lin H, Lin Y, Lin J, Peng F, Chen J, Yang Z. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China. Aging (Albany NY) 2020;12:15938-45. [PMID: 32855361 DOI: 10.18632/aging.103632] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
45 Chang R, Elhusseiny KM, Yeh Y, Sun W. COVID-19 ICU and mechanical ventilation patient characteristics and outcomes - A systematic review and meta-analysis.. [DOI: 10.1101/2020.08.16.20035691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Goldstein E, Yeghiazaryan K, Ahmad A, Giordano FA, Fröhlich H, Golubnitschaja O. Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations. EPMA J 2020;11:505-15. [PMID: 32839667 DOI: 10.1007/s13167-020-00221-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
47 Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R, Talukdar R, Sharma M, Qi X, Rao PN, Reddy DN. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther 2020;52:584-99. [PMID: 32638436 DOI: 10.1111/apt.15916] [Cited by in Crossref: 125] [Cited by in F6Publishing: 122] [Article Influence: 41.7] [Reference Citation Analysis]
48 Li G, Xu Y, Yang YT, Liu PF. Prevalence of acute liver injury and hypertransaminemia in patients with COVID-19: a protocol for a systematic review. BMJ Open 2020;10:e040517. [PMID: 32641369 DOI: 10.1136/bmjopen-2020-040517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
49 Wong YJ, Tan M, Zheng Q, Li JW, Kumar R, Fock KM, Teo EK, Ang TL. A systematic review and meta-analysis of the COVID-19 associated liver injury. Ann Hepatol 2020;19:627-34. [PMID: 32882393 DOI: 10.1016/j.aohep.2020.08.064] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
50 Leal-leyte P, Zamora-valdés D, Méndez-sánchez N. Enfermedad hepática y trasplante durante la pandemia COVID-19/SARS-CoV-2. Revista Mexicana de Trasplantes 2020;9:206-215. [DOI: 10.35366/94510] [Reference Citation Analysis]